Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer. - Kung CP; Cottrell KA; Ryu S; Bramel ER; Kladney RD; Bao EA; Freeman EC; Sabloak T; Maggi L Jr; Weber JD (Oncogene, 2021)